The Lynx Group
  • Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements
Personalized Medicine in Oncology
Subscribe
Subscribe to Personalized Medicine in Oncology

To sign up for our e-mail newsletter or print publications, fill out the information below and click Subscribe.

Country
Menu
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Continuing Education
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Continuing Education
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements

2014

November 2014
Part 4
  • View this Issue
September 2014
Part 3
  • View this Issue
June 2014
Part 2
  • View this Issue
April 2014
Part 1
  • View this Issue
December 2014
Vol 3, No 8
  • View this Issue
October 2014
Vol 3, No 7
  • View this Issue
September 2014
Vol 3, No 6
  • View this Issue
August 2014
Vol 3, No 5
  • View this Issue
June 2014
Vol 3, No 4
  • View this Issue
May 2014
Vol 3, No 3
  • View this Issue
April 2014
Vol 3, No 2
  • View this Issue
February 2014
Vol 3, No 1
  • View this Issue
In the News
    May 19, 2016

    Two-pronged attack on chemotherapy-resistant leukemia cells

    May 18, 2016

    An Early Look at Research From the 2016 ASCO Annual Meeting

    May 18, 2016

    Drug against breast cancer is also highly potent against a frequent form of leukaemia

    May 17, 2016

    Improving natural killer cancer therapy: Study

Sign me up!

Copyright 2022. Green Hill Healthcare Communications, LLC. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse the site you are agreeing to our use of cookies.